ArticleJACC. Heart failure2015

Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device.

Michael E Nassif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.